AIMP1 Gene Leukodystrophy hypomyelinating type 3 Genetic Test sale cost 4400 AED
GALC Gene Krabbe disease Genetic Test sale cost 4400 AED GALC Gene Krabbe disease Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
EIF2B3 Gene Leukoencephalopathy with vanishing white matter Genetic Test sale cost 4400 AED EIF2B3 Gene Leukoencephalopathy with vanishing white matter Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

AIMP1 Gene Leukodystrophy hypomyelinating type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The AIMP1 Gene Leukodystrophy Hypomyelinating Type 3 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the AIMP1 gene, which are associated with Hypomyelinating Leukodystrophy Type 3. This condition is a rare genetic disorder characterized by the abnormal development of the white matter in the brain, leading to a range of neurological symptoms and challenges. The test, priced at 4400 AED, involves the analysis of the patient’s DNA to detect specific genetic alterations in the AIMP1 gene, providing crucial information for accurate diagnosis, prognosis, and the potential for personalized treatment strategies. DNA Labs UAE employs state-of-the-art genetic testing technologies to ensure reliable and precise results, supporting patients and their families in understanding and managing this complex condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

AIMP1 Gene Leukodystrophy hypomyelinating type 3 Genetic Test

Components:

Price: 4400.0 AED

Sample Condition: Blood

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for AIMP1 Gene Leukodystrophy hypomyelinating type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AIMP1 Gene Leukodystrophy hypomyelinating type 3.

Test Details:

The AIMP1 gene is associated with a rare genetic disorder called Leukodystrophy hypomyelinating type 3. This disorder affects the myelin, which is the protective covering of nerve fibers in the brain and spinal cord. AIMP1 gene mutations can lead to abnormal development and maintenance of myelin, resulting in neurological symptoms.

NGS (Next-Generation Sequencing) Genetic Testing is a method used to analyze the DNA sequence of an individual’s genes. It can detect mutations or variations in specific genes, such as the AIMP1 gene, that may be responsible for a particular genetic disorder. NGS technology allows for the analysis of multiple genes simultaneously, providing a comprehensive assessment of an individual’s genetic profile.

Therefore, an AIMP1 gene NGS genetic test would involve sequencing the DNA of an individual to identify any mutations or variations in the AIMP1 gene that may be associated with Leukodystrophy hypomyelinating type 3. This test can help with the diagnosis, prognosis, and potential treatment options for individuals suspected of having this rare genetic disorder.

Test Name AIMP1 Gene Leukodystrophy hypomyelinating type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for AIMP1 Gene Leukodystrophy hypomyelinating type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with AIMP1 Gene Leukodystrophy hypomyelinating type 3
Test Details

The AIMP1 gene is associated with a rare genetic disorder called Leukodystrophy hypomyelinating type 3. This disorder affects the myelin, which is the protective covering of nerve fibers in the brain and spinal cord. AIMP1 gene mutations can lead to abnormal development and maintenance of myelin, resulting in neurological symptoms.

NGS (Next-Generation Sequencing) Genetic Testing is a method used to analyze the DNA sequence of an individual’s genes. It can detect mutations or variations in specific genes, such as the AIMP1 gene, that may be responsible for a particular genetic disorder. NGS technology allows for the analysis of multiple genes simultaneously, providing a comprehensive assessment of an individual’s genetic profile.

Therefore, an AIMP1 gene NGS genetic test would involve sequencing the DNA of an individual to identify any mutations or variations in the AIMP1 gene that may be associated with Leukodystrophy hypomyelinating type 3. This test can help with the diagnosis, prognosis, and potential treatment options for individuals suspected of having this rare genetic disorder.

SKU: TEST-1508 Category:

Related products